Cardiovascular effects of valdecoxib: transducing human pharmacology results into clinical read-outs

Author： Capone Marta L   Tacconelli Stefania   Francesco Luigia Di   Petrelli Maria   Patrignani Paola  

Publisher： Informa Healthcare

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.7, Iss.1, 2008-01, pp. : 29-42

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fondaparinux: Pharmacology and Clinical Experience in Cardiovascular Medicine

By  

Mini Reviews in Medicinal Chemistry, Vol. 7, Iss. 4, 2007-04 ,pp. : 383-387

Bentham Science Publishers

Access to resources Recommend Favorite

NO-NSAIDs: From Inflammatory Mediators to Clinical Readouts

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 5, Iss. 2, 2006-04 ,pp. : 121-131

Bentham Science Publishers

Access to resources Recommend Favorite

Valdecoxib

By Ormrod D.   Wellington K.   Wagstaff A.J.  

Drugs, Vol. 62, Iss. 14, 2002-01 ,pp. : 2059-2071

Adis International

Access to resources Recommend Favorite

Glycoprotein IIb/IIIa Receptor Antagonists: Clinical Pharmacology in Cardiovascular Diseases of Aging

By Sebastian M.   Makkar R.  

Drugs & Aging, Vol. 15, Iss. 3, 1999-09 ,pp. : 207-218

Adis International

Access to resources Recommend Favorite

Update on Cardiovascular Safety of PPARgamma Agonists and Relevance to Medicinal Chemistry and Clinical Pharmacology

By  

Current Topics in Medicinal Chemistry, Vol. 12, Iss. 6, 2012-03 ,pp. : 585-604

Bentham Science Publishers

Access to resources Recommend Favorite